CHARM Therapeutics
CHARM Therapeutics is a biotechnology company focused on delivering transformational medicines through 3D deep learning and cutting-edge drug discovery technologies. They leverage their proprietary DragonFold technology, inspired by Nobel Prize winner David Baker, which is described as the first rapid, accurate protein-ligand co-folding algorithm. This technology is used to develop a pipeline of novel small molecule inhibitors targeting cancers and other diseases with high unmet medical need. The company aims to address the 85% of the human proteome that remains undruggable by applying revolutionary insights in 3D protein-ligand co-folding. Their team is composed of scientists, engineers, and entrepreneurs dedicated to solving major problems in biology and drug discovery.
CHARM Therapeutics
CHARM Therapeutics is a biotechnology company focused on delivering transformational medicines through 3D deep learning and cutting-edge drug discovery technologies. They leverage their proprietary DragonFold technology, inspired by Nobel Prize winner David Baker, which is described as the first rapid, accurate protein-ligand co-folding algorithm. This technology is used to develop a pipeline of novel small molecule inhibitors targeting cancers and other diseases with high unmet medical need. The company aims to address the 85% of the human proteome that remains undruggable by applying revolutionary insights in 3D protein-ligand co-folding. Their team is composed of scientists, engineers, and entrepreneurs dedicated to solving major problems in biology and drug discovery.